[
    [
        {
            "time": "",
            "orginal_text": "第十七届发审委2018年第51次工作会议公告",
            "features": {
                "keywords": [
                    "发审委",
                    "工作会议",
                    "公告"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "证券"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "第十七届发审委2018年第51次工作会议公告",
            "scores": {
                "News_content": "第十七届发审委2018年第51次工作会议公告",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "orginal_text": "速读社丨华润医药营收1390亿元 AbbVie放弃寻求Rova-T加速批准",
            "features": {
                "keywords": [
                    "华润医药",
                    "营收",
                    "AbbVie",
                    "Rova-T",
                    "加速批准"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "速读社丨华润医药营收1390亿元 AbbVie放弃寻求Rova-T加速批准",
            "scores": {
                "News_content": "速读社丨华润医药营收1390亿元 AbbVie放弃寻求Rova-T加速批准",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "人类寿命没有极限？独家专访哈佛大学David Sinclair博士",
            "features": {
                "keywords": [
                    "人类寿命",
                    "哈佛大学",
                    "David Sinclair",
                    "生物科技"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "健康"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "人类寿命没有极限？独家专访哈佛大学David Sinclair博士",
            "scores": {
                "News_content": "人类寿命没有极限？独家专访哈佛大学David Sinclair博士",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "CDR传闻频出真假难辨 拟IPO“独角兽”静候上市东风",
            "features": {
                "keywords": [
                    "CDR",
                    "传闻",
                    "独角兽",
                    "上市"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "CDR传闻频出真假难辨 拟IPO“独角兽”静候上市东风",
            "scores": {
                "News_content": "CDR传闻频出真假难辨 拟IPO“独角兽”静候上市东风",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]